🇺🇸 FDA
Patent

US 6068976

Modulators of ob gene and screening methods therefor

expired A61KA61K38/00

Quick answer

US patent 6068976 (Modulators of ob gene and screening methods therefor) held by Ligand Pharmaceuticals Incorporated expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K38/00